Scleroderma Completed Phase 3 Trials for Tadalafil (DB00820)

Also known as: Dermatosclerosis

IndicationStatusPhase
DBCOND0013449 (Scleroderma)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01117298A Randomized Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in SclerodermaTreatment